Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Fresh Tracks Therapeutics Inc
Bullboard Posts
User Avatar Image
(5)
•••
Comment by MilitaryManon Jan 09, 2017 6:40am
250 Views
Post# 25682012

RE:A pleasure to read (Can not go wrong for BBI).

RE:A pleasure to read (Can not go wrong for BBI).https://www.encana.com/pdf/investors/presentations-events/corporate-presentation.pdf

Pipestone average D&C costs down to $4.4MM/well.

Maybe stage can help drive costs lower?


Four new Pipestone wells on-stream in Q3
 
Average IP30 1,900 BOE/d with 1,050bbls/d of condensate


A helpful comparable for us when we get our own news?

 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities